Evidence map›Paper›PMID 14567648›Full record

ArticlePharmaceutical research2003

Transdermal reverse iontophoresis of valproate: a noninvasive method for therapeutic drug monitoring.

M Begoña Delgado-Charro, Richard H Guy

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

M Begoña Delgado-CharroSchool of Pharmacy, University of Geneva, CH-1211 Geneva, Switzerland, and Centre International de Recherche et d'Enseignement, Pharmapeptides Archamps, France. Begonia.Delgado@pharm.unige.ch
Richard H Guy
Peptides International (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe objectives of this work were (a) to explore the potential of transdermal reverse iontophoresis for therapeutic drug monitoring and (b) to develop an "internal standard" calibration procedure so as to render the technique completely noninvasive.

methodsA series of in vitro iontophoresis experiments was performed in which the subdermal concentration of sodium valproate was varied from 21 microM to 1 mM. Glutamic acid was also introduced into the subdermal donor at a fixed concentration to act as an "internal standard" for the calibration method.

resultsBoth valproate and glutamate anions were recovered, as expected, at the anodal receptor chamber. The iontophoretic extraction flux of valproate was linearly correlated with the subdermal concentration. Glutamate flux was constant. It follows that the ratio of extracted fluxes (valproate/glutamate) was directly dependent upon (a) the subdermal valproate concentration and (b) the subdermal concentration ratio (valproate/glutamate), offering a means, thereby, to a completely noninvasive methodology.

conclusionsThis work demonstrates the potential of reverse iontophoresis for noninvasive therapeutic monitoring. The simultaneous quantification of the analyte of interest and of an "internal standard" renders the withdrawal of a blood sample unnecessary.

Indexed as

Administration, CutaneousAnimalsCalibrationDrug MonitoringFeasibility StudiesGlutamic AcidIn Vitro TechniquesIontophoresisSkinSkin AbsorptionSwineTime FactorsValproic AcidGlutamic AcidValproic Acid

Identifiers

PMID14567648
OpenAlexW1686185333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.